Sickle Cell Anemia Drug Shown Safe and Effective for Infants and Toddlers, Improving Treatment Options
St. Jude Children's Research HospitalThe multicenter Baby HUG trial led by St. Jude Children’s Research Hospital investigators shows hydroxyurea reduces the most common symptoms of sickle cell anemia in children, raising hopes the drug will ease complications and improve patient quality of life.